4.5 Article

Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases

Journal

RMD OPEN
Volume 7, Issue 1, Pages -

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/rmdopen-2021-001594

Keywords

vaccination; COVID-19; autoimmune diseases

Categories

Ask authors/readers for more resources

This paper reviews the current data on COVID-19 infection in patients with autoimmune inflammatory rheumatic diseases (AIIRD) and discusses the efficacy and safety of vaccination against COVID-19 in this population. It proposes preliminary considerations for vaccination based on expert opinion and knowledge of vaccination in AIIRD patients.
In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This position paper summarises the current data on COVID-19 infection in patients with AIIRD and development of vaccines against COVID-19, discusses the aspects of efficacy and safety of vaccination, and proposes preliminary considerations on vaccination against COVID-19 in patients with AIIRD, mainly based on the expert opinion and knowledge on the use of other vaccines in this population of patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available